Ibnsina Pharma reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was EGP 4,914.04 million compared to EGP 5,367.11 million a year ago. Net income was EGP 29.64 million compared to EGP 56.34 million a year ago. Basic earnings per share from continuing operations was EGP 0.02 compared to EGP 0.0429 a year ago.
For the six months, sales was EGP 10,214.78 million compared to EGP 10,123.52 million a year ago. Net income was EGP 86.91 million compared to EGP 106.71 million a year ago. Basic earnings per share from continuing operations was EGP 0.06 compared to EGP 0.0771 a year ago.